Richard Meyermann

13.9k total citations · 3 hit papers
242 papers, 11.1k citations indexed

About

Richard Meyermann is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Richard Meyermann has authored 242 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 47 papers in Genetics and 45 papers in Immunology. Recurrent topics in Richard Meyermann's work include Glioma Diagnosis and Treatment (45 papers), Neuroinflammation and Neurodegeneration Mechanisms (29 papers) and S100 Proteins and Annexins (19 papers). Richard Meyermann is often cited by papers focused on Glioma Diagnosis and Treatment (45 papers), Neuroinflammation and Neurodegeneration Mechanisms (29 papers) and S100 Proteins and Annexins (19 papers). Richard Meyermann collaborates with scholars based in Germany, United States and Switzerland. Richard Meyermann's co-authors include Hermann J. Schluesener, Michael Weller, Michel Mittelbronn, Christopher Linington, Hartmut Wekerle, Martin H. Deininger, Jan M. Schwab, Rudi Beschorner, Hans Lassmann and Wolfgang Wick and has published in prestigious journals such as The Lancet, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Richard Meyermann

241 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular immune reactivity within the CNS

1986 634 citations Hans Lassmann, Richard Meyermann et al. profile →
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

2010 627 citations Christian Hartmann, Wolfgang Wick et al. profile →
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

2009 571 citations Wolfgang Wick, Christian Hartmann et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Richard Meyermann

Since Specialization

Citations

This map shows the geographic impact of Richard Meyermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Meyermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Meyermann more than expected).

Fields of papers citing papers by Richard Meyermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Meyermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Meyermann. The network helps show where Richard Meyermann may publish in the future.

Co-authorship network of co-authors of Richard Meyermann

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Meyermann. A scholar is included among the top collaborators of Richard Meyermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Meyermann. Richard Meyermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparing the expression of integrins alpha v beta 3, alpha v beta 5, alpha v beta 6, alpha v beta 8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors 2013 ·International Journal of Clinical and Experimental Pathology ·Jens Schittenhelm, (unknown), Richard Meyermann, Falko Fend, Bence Sipos, Marcos Tatagiba	14
2	Longitudinal Expression Analysis of alpha v Integrins in Human Gliomas Reveals Upregulation of Integrin alpha v beta 3 as a Negative Prognostic Factor 2013 ·Journal of Neuropathology & Experimental Neurology ·Jens Schittenhelm, (unknown), Jan Sperveslage, Marcos Tatagiba, Richard Meyermann, Falko Fend, Bence Sipos	1
3	Paediatric clear cell meningioma with multiple distant recurrences after presumed intra-operative cell spread 2012 ·Child s Nervous System ·(unknown), Jens Schittenhelm, Oliver Schwartz, Richard Meyermann, Martin U. Schuhmann	9
4	Application of Mutant IDH1 Antibody to Differentiate Diffuse Glioma From Nonneoplastic Central Nervous System Lesions and Therapy-induced Changes 2010 ·The American Journal of Surgical Pathology ·David Capper, Felix Sahm, Christian Hartmann, Richard Meyermann, Andreas von Deimling, Jens Schittenhelm	98
5	NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide breakdown → 2009 ·Journal of Clinical Oncology ·Wolfgang Wick, Christian Hartmann, Corinna Engel, Mandy Stoffels, Jörg Felsberg, Florian Stockhammer, Michael Sabel, Susanne Koeppen, Ralf Ketter, Richard Meyermann, Marion Rapp, C Meisner, Rolf D. Kortmann, Torsten Pietsch, Otmar D. Wiestler, Ulrike Ernemann, Michael Bamberg, Guido Reifenberger, Andreas von Deimling, Michael Weller	571
6	Rathke’s cleft cyst rupture as potential initial event of a secondary perifocal lymphocytic hypophysitis: proposal of an unusual pathogenetic event and review of the literature 2008 ·Neurosurgical Review ·Jens Schittenhelm, Rudi Beschorner, Tsambika Psaras, David Capper, Thomas Nägele, Richard Meyermann, Wolfgang Saeger, Jürgen Honegger, Michel Mittelbronn	30
7	Expression of EAAT1 reflects a possible neuroprotective function of reactive astrocytes and activated microglia following human traumatic brain injury. 2007 ·PubMed ·Rudi Beschorner, Klaus Dietz, Nicolas Schauer, Michel Mittelbronn, Hermann J. Schluesener, Katrin Trautmann, Richard Meyermann, Perikles Simon	51
8	Prolonged lesional expression of RhoA and RhoB following spinal cord injury 2005 ·The Journal of Comparative Neurology ·Sabine Conrad, Hermann J. Schluesener, Katrin Trautmann, Nicolas Joannin, Richard Meyermann, Jan M. Schwab	57
9	Immune cell infiltration of intrinsic and metastatic intracranial tumours. 2004 ·PubMed ·Herwig Strik, (unknown), Richard Meyermann	53
10	A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape 2002 ·The Journal of Immunology ·Heinz Wiendl, Meike Mitsdoerffer, Valeska Hofmeister, Jörg Wischhusen, Antje Bornemann, Richard Meyermann, Elisabeth H. Weiss, Arthur Melms, Michael Weller	291
11	Expression of EMAP-II by Activated Monocytes/Microglial Cells in Different Regions of the Rat Hippocampus after Trimethyltin-Induced Brain Damage 2002 ·Experimental Neurology ·Christine Brabeck, Fabrizio Michetti, Maria Concetta Geloso, Valentina Corvino, (unknown), Richard Meyermann, Hermann J. Schluesener	40
12	Analysis of mdm2 and p53 Gene Alterations in Glioblastomas and its Correlation with Clinical Factors 2000 ·Journal of Neuro-Oncology ·(unknown), Petra Ohneseit, W. H. Hoffmann, Richard Meyermann, H. Peter Rodemann, (unknown)	51
13	Allograft Inflammatory Factor-1 Is Expressed By Macrophages in Injured Skeletal Muscle and Abrogates Proliferation and Differentiation of Satellite Cells 2000 ·Journal of Neuropathology & Experimental Neurology ·(unknown), Martin H. Deininger, Richard Meyermann, Antje Bornemann, Zipora Yablonka‐Reuveni, Hermann J. Schluesener	41
14	Allograft-Inflammatory-factor-1 is upregulated in microglial cells in human cerebral infarctions 2000 ·Journal of Neuroimmunology ·E. Postler, Andreas Rimner, Rudi Beschorner, Hermann J. Schluesener, Richard Meyermann	59
15	Expression of microglial markers in the human CNS after closed head injury. 1996 ·PubMed ·St. Engel, (unknown), Richard Meyermann	20
16	Cloning of a novel TGF‐β related cytokine, the vgr, from rat brain: Cloning of and comparison to homologous human cytokines 1992 ·Journal of Neuroscience Research ·Ulrike Sauermann, Richard Meyermann, Hermann J. Schluesener	12
17	CHRONIC RELAPSING EXPERIMENTAL ALLERGIC NEURITIS INDUCED BY REPEATED TRANSFER OF P₂-PROTEIN REACTIVE T CELL LINES 1991 ·Brain ·Hans Lassmann, Walter Fierz, Csilla Neuchrist, Richard Meyermann	20
18	The Peplomer Protein E2 of Coronavirus JHM as a Determinant of Neurovirulence: Definition of Critical Epitopes by Variant Analysis 1988 ·Journal of General Virology ·H. Wege, Jörn Winter, Richard Meyermann	55
19	Endothelialization of a new arterial microvascular graft material. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·(unknown), (unknown), (unknown), (unknown), Richard Meyermann, (unknown)	6
20	Ultrastructural findings after microsurgical interventions on the carotid artery of the rat 1976 ·Acta Neurochirurgica ·Richard Meyermann, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact